Comparison of Acarbose and Voglibose in Diabetes Patients Who Are Inadequately Controlled with Basal Insulin Treatment: Randomized, Parallel, Open-Label, Active-Controlled Study

@inproceedings{Lee2014ComparisonOA,
  title={Comparison of Acarbose and Voglibose in Diabetes Patients Who Are Inadequately Controlled with Basal Insulin Treatment: Randomized, Parallel, Open-Label, Active-Controlled Study},
  author={Mi Young Lee and Dong Seop Choi and Moon Kyu Lee and Hyoung Woo Lee and Tae Sun Park and Doo Man Kim and Choon Hee Chung and Duk Kyu Kim and In Joo Kim and Hak Chul Jang and Yongsoo Park and Hyuk Sang Kwon and Seung Hun Lee and Hee Kang Shin},
  booktitle={Journal of Korean medical science},
  year={2014}
}
We studied the efficacy and safety of acarbose in comparison with voglibose in type 2 diabetes patients whose blood glucose levels were inadequately controlled with basal insulin alone or in combination with metformin (or a sulfonylurea). This study was a 24-week prospective, open-label, randomized, active-controlled multi-center study. Participants were randomized to receive either acarbose (n=59, 300 mg/day) or voglibose (n=62, 0.9 mg/day). The mean HbA1c at week 24 was significantly… CONTINUE READING